Conmed Stock Story
| CNMD Stock | USD 71.08 1.68 2.31% |
About 56% of CONMED's investor base is looking to short. The analysis of overall sentiment of trading CONMED stock suggests that many investors are alarmed at this time. CONMED's investor sentiment overview provides quick insight into current market opportunities from investing in CONMED. The current market sentiment, together with CONMED's historical and current headlines, can help investors time the market. In addition, many technical investors use CONMED stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
CONMED stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of CONMED daily returns and investor perception about the current price of CONMED as well as its diversification or hedging effects on your existing portfolios.
CONMED |
Requested story not found. it has been either deleted or moved. View all stories for CONMED.
CONMED Latest Timeline
CONMED is listed for 71.08. The company reported the previous year's revenue of 1.24 B. Net Income was 64.46 M with profit before overhead, payroll, taxes, and interest of 575.75 M.Check out CONMED Hype Analysis, CONMED Correlation and CONMED Performance. For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for CONMED Stock analysis
When running CONMED's price analysis, check to measure CONMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CONMED is operating at the current time. Most of CONMED's value examination focuses on studying past and present price action to predict the probability of CONMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CONMED's price. Additionally, you may evaluate how the addition of CONMED to your portfolios can decrease your overall portfolio volatility.
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |
Is CONMED's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CONMED. If investors know CONMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CONMED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.213 | Dividend Share 0.8 | Earnings Share 2.04 | Revenue Per Share 40.588 | Quarterly Revenue Growth 0.304 |
The market value of CONMED is measured differently than its book value, which is the value of CONMED that is recorded on the company's balance sheet. Investors also form their own opinion of CONMED's value that differs from its market value or its book value, called intrinsic value, which is CONMED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CONMED's market value can be influenced by many factors that don't directly affect CONMED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CONMED's value and its price as these two are different measures arrived at by different means. Investors typically determine if CONMED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.